Loading clinical trials...
Loading clinical trials...
An Open-safety Study of the siCoV/KK46 Drug Administered Via an Inhaled Route in Healthy Volunteers
Conditions
Interventions
siCoV/KK46
Locations
1
Russia
NRC Institute of Immunology FMBA
Moscow, Russia
Start Date
January 22, 2021
Primary Completion Date
March 26, 2021
Completion Date
March 26, 2021
Last Updated
January 26, 2022
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions